
The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses to the “JN.1” coronavirus lineage.

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses to the “JN.1” coronavirus lineage.
Wuhu, China — (ARAB NEWSWIRE) — Driven by evolving government policies, expanding charging infrastructure, and consumer…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
Backed by Ananda Impact Ventures and ReGen Ventures, along with Carbon13, Climate Capital, Better Ventures, CDTM Ventures, and several angel…
Lynozyfic is one of two bispecific antibodies Regeneron hopes will lift its oncology business. Meanwhile, IGM is the latest struggling…
Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in…
Arming NK cells with enhanced antitumor activity. Source: Oberoi P, Wels WS – Oncoimmunology (2013) I attended and participated in…
Sign in to your account